Exelixis (EXEL) stock

Last close 70.58 USD (Nov 10, 2026), on the day −1.6 %.

• Sector: Healthcare, Biotechnology.
• Market cap: 17.5B USD.
• P/E: 20.9. Forward P/E: 16.8.
• Over 52 weeks: low 40.74 USD, high 72.75 USD, price change +70.4 %.
• Analysts' average 12-month target from Yahoo Finance: 62 USD (14 analysts). Not our estimate.

Earnings

• Feb 9, 2027: EPS not yet, estimate 1.03
• Oct 29, 2026: EPS 0.94, estimate 0.90
• Aug 5, 2026: EPS 0.91, estimate 0.86
• May 5, 2026: EPS 0.87, estimate 0.76
• Feb 10, 2026: EPS 0.94, estimate 0.81
• Nov 4, 2025: EPS 0.78, estimate 0.67

Which large investors hold it

• Ray Dalio – 0.1 % of the portfolio

In baskets

• Biotech

Similar companies: ARGX · BMRN · BNTX · INCY · MRNA · REGN · VRTX